雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

EARLY ADENINE ARABINOSIDE THERAPY IN HERPES SIMPLEX ENCEPHALITIS (HSE) Keizo Hirayama 1 , Naoki Ito 1 , Mitsuru Kawamura 1 , Tatsuo Yamada 1 , Yukio Tokumaru 1 , Toshifumi Asahi 2 , Yukitaka Hiyama 3 1Department of Neurology, Brain Research Institute, School of Medicine, Chiba University 2Department of Neurology, Matsudo City Hospital 3Department of Neurology, Kawatetsu Hospital pp.873-880
Published Date 1982/9/1
DOI https://doi.org/10.11477/mf.1406204997

閲覧方法のご案内

この論文を閲覧するためにはログインが必要になります。
パスワードを忘れた場合 新しくユーザー登録する 施設共通IDをご利用の方はこちらから

PPV購入案内

1,320円 (1,200円+税10%) こちらは、873ページから880ページの文献です。
PPV(ペイ・パー・ビュー)とは、論文(記事)単位で購入・閲覧ができるサービスです。
購入には医書.jp本会員登録が必要です。



会員登録完了後に改めて上記「購入サイトへ」を選択してください。
または「購入サイトへ」選択後に「購入ログイン」、「新規会員登録」の順に進んでください。

会員登録について詳しくはをご確認ください。
  • Abstract
  • Look Inside

Five patients with HSE were treated with adenine arabinoside and one additional patient with cytosine arabinoside. The diagnosis of HSEwas confirmed in retrospect by the rising CF titers and the Enzyme-Linked Immunosorbent Assay (ELISA) levels in CSF (Table 2). Brain biopsy was not performed.

The treatment was started promptly when HSE was strongly suspected by symptoms and signs, EEG, CT and CSF findings before the specific laboratory data were available. The clinical and laboratory data on the 6 patients were shown in Table 1.

All the 5 patients of HSE treated with adenine arabinoside survived: 3 returned to normal daily life, including one having no neurological deficits, and the other 2 had mild to moderate memory disturbances. Improvement of CT abnormalities indicated a good prognosis. Age or sex did not have influence on the prognosis. The patient treated with cytosine arabinoside died of compli-cations after being in a state of apallic syndromefor 1 year and 8 months.

On the basis of the analysis of our patients, one of the crucial factors in the treatment of HSE seems to be the earliest possible use of adenine arabinoside : in our patients on the 2nd up to 9th day of onset, although there was no correlation between the day the medication was started and the morbidity.

The other important factor includes the manage-ment of acute stage of HSE: the treatment of cerebral edema and generalized convulsions. The major side effects of adenine arabinoside included diarrhea (one case), elevation of GOT, GPT or LDH (one case) which all improved after the treatment.

Adenine arabinoside could be an effective drug for HSE reducing the mortality and morbidity with few side effects.


Copyright © 1982, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 2185-405X 印刷版ISSN 0006-8969 医学書院

関連文献

もっと見る

文献を共有